By inhibiting the aggregation of M1 macrophages and inhibiting the chronic inflammation of adipose tissue and liver mediated by inflammation, metabolic disorders and chronic inflammation could be improved, and the insulin sensitivity could be increased. This evidence concerns the gene INS and metabolic disease.